Hot Stocks
|
Shares of CVS Health… Shares of CVS Health (CVS) are up about 1% in afternoon trading after CNBC reported that Haven, the joint venture that Amazon (AMZN), Berkshire Hathaway (BRK.A) and JPMorgan (JPM) had launched with an eye on disrupting the existing healthcare model, will shut down by the end of next month. Other publicly traded companies in the healthcare insurance space that could react to the Haven news include Anthem (ANTM), Centene (CNC), Cigna (CI), Health Net (HNT), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH) and WellCare (WCG). ShowHide Related Items >><< - 12/08/20
- Massachusetts sues three UnitedHealth companies for 'misleading consumers'
- 12/04/20
- Eli Lilly, UnitedHealth partner on study of bamlanivimab for COVID-19
- 11/20/20
- UnitedHealth appoints Matthew Friedrich as CLO
- 11/19/20
- Molina Healthcare to begin CFO transition with retirement of Tom Tran in 2021
- 09/29/20
- Molina Healthcare to acquire Affinity Health Plan for $380M
- 07/17/20
- Evolent Health says Molina Healthcare to acquire assets of Passport Health
- 07/17/20
- Molina Healthcare to acquire certain assets of Passport Health Plan for ~$20M
- 01/04/21
- LiveXLive Media expands review of strategic opportunities
- 12/29/20
- Alpha One Capital's Dan Niles likes JPMorgan, Oracle, Magna Intl, Gan Ltd in '21
- 12/28/20
- JPMorgan acquires global loyalty business of cxLoyalty
- 12/21/20
- Great Elm Capital announces financing pact with JPMorgan
- 12/16/20
- SI-Bone announces Humana coverage for iFuse in MIS SI joint fusion procedures
- 12/02/20
- Humana signs agreement with Prime West to bring medical care to Las Vegas
- 11/16/20
- Appaloosa exits Broadcom, Qualcomm positions, boosts PG&E stake
- 01/03/21
- Fly Intel: Top five weekend stock stories
- 12/28/20
- CA Governor announces partnership with CVS, Walgreens to provide COVID vaccines
- 12/22/20
- Pharmacy stocks lower after DoJ files prescription drug suit against Walmart
- 12/21/20
- CVS Health begins administering COVID-19 vaccines in long-term care facilities
- 01/04/21
- Centene to acquire Magellan Health for $95.00 per share in cash
- 12/30/20
- Centene completes acquisition of PANTHERx Rare Pharmacy
- 12/18/20
- Deerfield Healthcare Technology Acquisitions agrees to merger with CareMax
- 12/15/20
- Centene to acquire PANTHERx, terms not disclosed
- 12/10/20
- Cigna appoints Brian Evanko as CFO
- 11/16/20
- Omega takes Alphabet Class A stake, exits position in JPMorgan
- 11/04/20
- Cigna rises 10.8%
- 11/04/20
- Cigna rises 9.5%
- $341,500.00 /
-6702 (-1.92%) - 12/20/20
- Fly Intel: Top five weekend stock stories
- 12/03/20
- Berkshire Hathaway Annual Meeting of Shareholders to be held May 1, 2021
- 11/08/20
- Fly Intel: Top five weekend stock stories
- 11/02/20
- Dominion closes on sale of majority of gas transmission & storage assets
- 12/16/20
- Anthem names Shantanu Agrawal as Chief Health Officer
- 11/01/20
- Fly Intel: Top five weekend stock stories
- 10/28/20
- Anthem confirms $594M Blue Cross Blue Shield antitrust settlement
- $3,157.05 /
-100.155 (-3.07%) - 12/30/20
- Podcast creator and producer Wondery to join Amazon Music
- 12/28/20
- FAA adopts final rules for drones 'advancing opportunities' for utilization
- 12/23/20
- Amazon to delay planned increase in merchant fees for storing, shipping items
- 12/22/20
- FDA warns Amazon's Whole Foods for misbranding food products
- 12/22/20 JPMorgan
- Latest Georgia polling favors Republicans, says JPMorgan
- 12/18/20 Mizuho
- Cigna price target raised to $229 from $220 at Mizuho
- 11/17/20 Oppenheimer
- Amazon's Pharmacy push should continue to disrupt supply chain, says Oppenheimer
- 11/17/20 Piper Sandler
- Amazon entry into Pharmacy makes 'great deal of sense,' says Piper Sandler
- 01/04/21 Cowen
- Centene deal for Magellan makes 'strategic sense,' says Cowen
- 12/21/20 Deutsche Bank
- Centene price target lowered to $77 from $83 at Deutsche Bank
- 11/16/20 Citi
- Citi opens 'negative catalyst watch' on Centene
- 11/17/20 Goldman Sachs
- Goldman says Amazon news likely to pressure entire pharmacy supply chain
- 11/11/20 Piper Sandler
- CVS Health price target raised to $76 from $72 at Piper Sandler
- 01/04/21
- Fly Intel: Top five analyst upgrades
- 01/04/21
- Humana upgraded to Outperform at RBC Capital on above-average MA growth
- 01/04/21 RBC Capital
- Humana upgraded to Outperform from Sector Perform at RBC Capital
- 12/03/20 Deutsche Bank
- UnitedHealth price target raised to $359 from $332 at Deutsche Bank
- 12/02/20 BMO Capital
- UnitedHealth price target raised to $395 from $385 at BMO Capital
- 12/02/20 Truist
- UnitedHealth price target raised to $400 from $380 at Truist
- 09/21/20 Citi
- Citi sees ACA remaining law despite Ginsburg death
- 03/04/20 Jefferies
- Centene 2020 EPS view hurt by possible NY rate cut, says Jefferies
- 02/05/20 Credit Suisse
- Centene price target raised to $72.50 from $65 at Credit Suisse
- 01/10/20 Piper Sandler
- WellCare downgraded to Neutral from Overweight at Piper Sandler
- 11/11/20 Piper Sandler
- Molina Healthcare price target raised to $266 from $213 at Piper Sandler
- 10/13/20 Truist
- Truist raises price targets on select Healthcare Services names
- 09/30/20 Truist
- Molina Healthcare risk-reward attractive after Affinity Health deal, says Truist
- 12/18/20 Mizuho
- Anthem price target raised to $320 from $300 at Mizuho
- 11/11/20 Piper Sandler
- Anthem price target raised to $369 from $330 at Piper Sandler
- 11/06/20 JPMorgan
- Anthem price target raised to $389 from $324 at JPMorgan
- 10/29/20 SVB Leerink
- Anthem price target raised to $370 from $345 at SVB Leerink
- 01/04/21 Barclays
- JPMorgan price target raised to $164 from $144 at Barclays
- 12/14/20 Keefe Bruyette
- Universal Banks upgraded to Overweight from Market Weight at Keefe Bruyette
- 12/11/20 Credit Suisse
- JPMorgan price target raised to $142 from $126 at Credit Suisse
- 12/09/20 RBC Capital
- JPMorgan price target raised to $130 from $110 at RBC Capital
- $3,157.05 /
-100.155 (-3.07%) - 12/22/20 Wells Fargo
- Microsoft's own semis 'a competitive headwind' for Intel, says Wells Fargo
- 12/16/20 Baird
- Baird would be a buyer of Teladoc amid weakness caused by Amazon report
- 12/14/20 BMO Capital
- BMO downgrades Disney after recent run, names new top media pick
- 12/03/20 Rosenblatt
- Ambarella price target raised to $100 from $82 at Rosenblatt
- $341,500.00 /
-6702 (-1.92%) - 07/07/20 Argus
- Dominion price target lowered to $80 from $87 at Argus
- 07/06/20 Guggenheim
- Guggenheim 'loves' Dominion gas transmission sale, decision to scrap pipeline
- 04/06/20 Citi
- Delta not 'broken story' but share weakness may persist, says Citi
- 12/01/20
- UnitedHealth sees FY21 adjusted EPS $17.75-$18.25, consensus $18.33
- 12/01/20
- UnitedHealth raises FY20 adj. EPS view to approach $16.75 from $16.50-$16.75
- 10/14/20
- UnitedHealth raises FY20 adj. EPS view to $16.50-$16.75 from $16.25-$16.55
- 10/14/20
- UnitedHealth reports Q3 adj. EPS $3.51, consensus $3.09
- 10/28/20
- Molina Healthcare says FY21 improved with Affinity deal
- 10/28/20
- Molina Healthcare raises FY20 revenue view to roughly $19.6B from $18.8B
- 10/28/20
- Molina Healthcare reports Q3 adjusted EPS $3.36, consensus $2.16
- 10/28/20
- Notable companies reporting after market close
- 10/13/20
- JPMorgan reports Q3 EPS $2.92, consensus $2.23
- 10/12/20
- Notable companies reporting before tomorrow's open
- 10/12/20
- Fly Intel: What to watch in first round of big bank earnings reports
- 11/03/20
- Humana sees Q4 adjusted EPS approximately ($2.40), consensus ($1.78)
- 11/03/20
- Humana narrows FY20 adj. EPS view to $18.50-$18.75 from $18.25-$18.75
- 11/03/20
- Humana reports Q3 adjusted EPS $3.08, consensus $2.81
- 11/02/20
- Notable companies reporting before tomorrow's open
- 11/06/20
- CVS Health raises FY20 adj. EPS view to $7.35-$7.45 from $7.14-$7.27
- 11/06/20
- CVS Health reports Q3 adj. EPS $1.66, consensus $1.33
- 11/05/20
- Notable companies reporting before tomorrow's open
- 12/18/20
- Centene backs FY20 adjusted EPS view $4.90-$5.06, consensus $4.99
- 12/18/20
- Centene sees FY21 adjusted EPS $5.00-$5.30, consensus $5.44
- 10/27/20
- Centene raises FY20 adj. EPS view to $4.90-$5.06 from $4.76-$4.96
- 10/27/20
- Centene reports Q3 adj. EPS $1.26, consensus 96c
- 11/05/20
- Cigna sees FY20 adjusted EPS $18.30-$18.60, consensus $18.55
- 11/05/20
- Cigna reports Q3 adjusted EPS $4.41, consensus $4.24
- 11/04/20
- Notable companies reporting before tomorrow's open
- $341,500.00 /
-6702 (-1.92%) - 11/08/20
- Berkshire Hathaway reports Q3 EPS $18,994 vs. $10,119 last year
- 08/08/20
- Berkshire Hathaway buys back $5.1B in Berkshire stock during Q2
- 08/08/20
- Berkshire Hathaway reports Q2 net earnings $26.3B vs. $14.1B last year
- 10/28/20
- Anthem: View of 2021 affirms LT EPS growth rate of 12%-15%, consensus $25.37
- 10/28/20
- Anthem sees FY20 adjusted EPS greater than $22.30, consensus $22.47
- 10/28/20
- Anthem reports Q3 adjusted EPS $4.20, consensus $4.15
- 10/27/20
- Notable companies reporting before tomorrow's open
- $3,157.05 /
-100.155 (-3.07%) - 10/29/20
- Amazon.com sees Q4 revenue $112B-$121B, consensus $112.32B
- 10/29/20
- Amazon.com reports Q3 EPS $12.37, consensus $7.41
- 07/30/20
- Amazon.com sees Q3 sales $87B-$93B, consensus $86.29B
- 07/30/20
- Amazon.com reports Q2 EPS $10.30, consensus $1.46
- 10/01/20
- Insurers reduce coverage for virtual doctors' visits, WSJ reports
- 09/29/20
- UnitedHealth buys DivvyDose, a rival of Amazon's PillPack, CNBC says
- 01/04/21
- Amazon-Berkshire-JPMorgan healthcare joint venture to disband, CNBC says
- 12/31/20
- M&A activity rebounded into year-end to finish 2020 down just 5%, FT says
- 12/22/20
- Tech companies win as SEC permits direct IPOs for cash raise, Bloomberg says
- 12/17/20
- JPMorgan lost out to Morgan Stanley on Eaton Vance, FT reports
- 01/02/21
- Coca-Cola, Disney among value stocks deserving a fresh look, Barron's says
- 12/20/20
- CDC panel says frontline workers, people over 74 should be next, NYTimes reports
- 11/20/20
- Trump to release new rules aimed at lowering drug prices, WSJ reports
- 11/10/20
- Supreme Court appears unlikely to topple ACA, USA Today says
- 09/01/20
- Anthem-Cigna dispute over derailed merger ends in draw, WSJ reports
- 08/05/20
- Cigna sued by Justice Department for insurance fraud, Axios reports
- $341,500.00 /
-6702 (-1.92%) - 12/19/20
- Alphabet, Apple among Barron's 10 Top stocks for 2021, Barron's says
- 12/07/20
- Energizer, Duracell dismiss rival suits over battery life claims, Reuters says
- 09/15/20
- Snowflake IPO priced at $120 per share, CNBC reports
- 10/31/20
- Managed-care stocks, Anthem could rise after vote, Barron's says
- 09/24/20
- Blue Cross Blue Shield group reaches tentative antitrust settlement, WSJ says
- $3,157.05 /
-100.155 (-3.07%) - 12/29/20
- Apple supplier Lens Technology linked to forced labor in China, WaPo says
- 12/29/20
- Amazon's ads unit growing faster than retail, cloud computing units, FT says
- 12/23/20
- Formula One in talks with Amazon to stream Grand Prix races, FT reports
- 12/01/20
- Fly Intel: Wall Street's top stories for Tuesday
- 12/01/20
- Fly Intel: Wall Street's top stories at midday
- 12/01/20
- Fly Intel: Pre-market Movers
- 07/30/20
- Fly Intel: After-Hours Movers
- 07/17/20
- Fly Intel: Pre-market Movers
- 12/21/20
- Fly Intel: Pre-market Movers
- 11/30/20
- Apple upgrade, Slack downgrade among today's top calls on Wall Street
- 10/30/20
- The Intersection: Crypto and Wall Street This Week
- 10/13/20
- Fly Intel: Wall Street's top stories for Tuesday
- 09/01/20
- Fly Intel: Wall Street's top stories for Tuesday
- 09/01/20
- Fly Intel: Wall Street's top stories at midday
- 12/01/20
- Fly Intel: What to watch in Salesforce's earnings report
- 11/17/20
- Fly Intel: Pre-market Movers
- 01/04/21
- Fly Intel: Wall Street's top stories at midday
- 01/04/21
- Fly Intel: Pre-market Movers
- 10/27/20
- Fly Intel: Pre-market Movers
- 11/17/20
- Fly Intel: Wall Street's top stories for Tuesday
- 11/17/20
- Fly Intel: Wall Street's top stories at midday
- 11/17/20
- Pharmacy owners, suppliers slide after Amazon launches new offerings
- 11/14/20
- Week in review: How Trump's policies moved stocks
- $341,500.00 /
-6702 (-1.92%) - 12/02/20
- Fly Intel: What to watch in Snowflake earnings report
- 09/24/20
- Fly Intel: Wall Street's top stories for Thursday
- 09/24/20
- Fly Intel: Wall Street's top stories at midday
- 09/20/20
- Opening Day: Snowflake shares double in biggest software IPO ever
- 10/28/20
- Fly Intel: Pre-market Movers
- $3,157.05 /
-100.155 (-3.07%) - 12/19/20
- Week in review: How Trump's policies moved stocks
- 12/16/20
- #SocialStocks: Facebook speaks out against Apple iOS 14
- 12/16/20
- Teladoc slides on report of Amazon building telehealth business
- 12/14/20
- Fly Intel: Wall Street's top stories for Monday
- 10/14/20
- Unusually active option classes on open October 14th
- 07/15/20
- Unusually active option classes on open July 15th
- 08/05/20
- JPMorgan call volume above normal and directionally bullish
- 07/14/20
- Unusually active option classes on open July 14th
- 07/14/20
- Notable open interest changes for July 14th
- 07/13/20
- Unusually active option classes on open July 13th
- 11/17/20
- Unusually active option classes on open November 17th
- 11/10/20
- CVS Health call volume above normal and directionally bullish
- 11/06/20
- Early notable gainers among liquid option names on November 6th
- 11/06/20
- Unusually active option classes on open November 6th
- 10/13/20
- Centene put volume heavy and directionally bearish
- 09/21/20
- Centene put volume heavy and directionally bearish
- 09/01/20
- Centene put volume heavy and directionally bearish
- 08/31/20
- Centene call volume above normal and directionally bullish
- 11/04/20
- Early notable gainers among liquid option names on November 4th
- 10/30/20
- Cigna put volume heavy and directionally bearish
- 10/01/20
- Cigna put volume heavy and directionally bearish
- 09/15/20
- Cigna put volume heavy and directionally bearish
- $3,157.05 /
-100.155 (-3.07%) - 12/31/20
- Unusually active option classes on open December 31st
- 12/29/20
- Unusually active option classes on open December 29th
- 10/26/20
- Early notable gainers among liquid option names on October 26th
- 08/18/20
- Early notable gainers among liquid option names on August 18th
|
Upgrade
|
Catch up on today's… Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. AT&T (T) upgraded to Outperform from Market Perform at Raymond James with analyst Frank Louthan saying while he thinks Q4 is likely to be an unimpressive quarter, the analyst believes the situation improves for AT&T over the next 12 months, offering a solid total return story. 2. Molson Coors (TAP) upgraded to Buy from Hold at Jefferies with analyst Kevin Grundy saying that recovery potential is not adequately reflected in Molson Coors' share price. 3. Humana (HUM) upgraded to Outperform from Sector Perform at RBC Capital with analyst Frank Morgan saying the company is "well positioned" for strong growth in FY21 and beyond as its management anticipates an above-industry average growth in Individual Medicare Advantage. 4. Mettler-Toledo (MTD) upgraded to In Line from Underperform at Evercore ISI with analyst Vijay Kumar noting that the company's 4%-6% revenue growth outlook guided in November "seems conservative" given the strong China and Industrial rebounds in the last cycle" as it assumes a 4%-6% China growth vs. historical trends of 8%-10%. 5. Goldman Sachs (GS), Morgan Stanley (MS) and Ally Financial (ALLY) all upgraded to Overweight from Equal Weight at Barclays. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here. ShowHide Related Items >><< - 12/16/20
- Court denies Molson Coors' motion to dismiss Future Proof claim
- 12/01/20
- Molson Coors increases capacity for seltzers and "popular innovations" by 400%
- 10/30/20
- Molson Coors CEO says 'really pleased with where we are' with seltzers
- 10/16/20
- Theratechnologies appoints Andrew Molson, Alain Trudeau to board
- 12/22/20
- AT&T, communications union reach pacts on Mobility contract extensions
- 12/22/20
- Sony Pictures CEO says 'don't think' will move to 'day and date' film releases
- 12/16/20
- HBO Max to launch on Roku devices on December 17
- 12/16/20
- HBO Max now available on PlayStation 5 consoles
- $1,164.82 /
+24.79 (+2.17%) - 12/15/20
- Mettler-Toledo CEO Olivier Filliol to step down, Patrick Kaltenbach to succeed
- 11/05/20
- Mettler-Toledo announces additional $2.5B share repurchase program
- 08/13/20
- Mettler-Toledo enters collaboration with TetraScience
- 11/06/20
- Carlyle Group acquires Manna Pro Products from Morgan Stanley Capital Partners
- 10/19/20
- T. Rowe Price appoints Raymone Jackson as global head of diversity, inclusion
- 10/16/20
- House report shows Trump admin urged banks to give PPP loans to wealthy clients
- 12/18/20
- Deerfield Healthcare Technology Acquisitions agrees to merger with CareMax
- 12/16/20
- SI-Bone announces Humana coverage for iFuse in MIS SI joint fusion procedures
- 12/02/20
- Humana signs agreement with Prime West to bring medical care to Las Vegas
- 11/16/20
- Appaloosa exits Broadcom, Qualcomm positions, boosts PG&E stake
- 12/20/20
- Fly Intel: Top five weekend stock stories
- 12/18/20
- Goldman Sachs to resume share repurchases next quarter
- 12/18/20
- Fed to extend current restrictions on distributions with modifications
- 12/14/20
- Cushman & Wakefield appoints Nadine Augusta as CDEIO
- 12/08/20
- Ally Financial: Core trends 'look really strong' across the bank
- 12/08/20
- Ally Financial sees mid-teens returns over next 1-2 years
- 11/24/20
- Tiger Global led $131M in Series C funding for U.S. 'challenger bank' Current
- 10/16/20
- Ally Financial reports Q3 CET1 ratio 10.4%
- 01/04/21 Raymond James
- AT&T upgraded to Outperform from Market Perform at Raymond James
- 01/04/21 Raymond James
- AT&T upgraded to Outperform from Market Perform at Raymond James
- 12/24/20 Raymond James
- AT&T estimates lowered ahead of Q4 report at Raymond James
- 12/22/20 JPMorgan
- JPMorgan remains 'wary' on AT&T shares despite 'stable' dividend
- 01/04/21 Jefferies
- Jefferies upgrades 'recovery beneficiary' Molson Coors to Buy
- 01/04/21 Jefferies
- Molson Coors upgraded to Buy from Hold at Jefferies
- 12/07/20 Wells Fargo
- Molson Coors initiated with an Equal Weight at Wells Fargo
- 07/15/20 Bryan Garnier
- Molson Coors upgraded to Buy from Sell at Bryan Garnier
- 01/04/21
- Humana upgraded to Outperform at RBC Capital on above-average MA growth
- 01/04/21 RBC Capital
- Humana upgraded to Outperform from Sector Perform at RBC Capital
- 12/22/20 JPMorgan
- Latest Georgia polling favors Republicans, says JPMorgan
- 12/17/20 Canaccord
- SI-Bone price target raised to $34 from $30 at Canaccord
- $1,164.82 /
+24.79 (+2.17%) - 01/04/21
- Mettler-Toledo upgraded to In Line at Evercore ISI given strong rebound history
- 01/04/21 Evercore ISI
- Mettler-Toledo upgraded to In Line from Underperform at Evercore ISI
- 12/17/20 Cleveland Research
- Mettler-Toledo upgraded to Buy from Neutral at Cleveland Research
- 12/16/20 Citi
- Mettler-Toledo price target raised to $1,200 from $1,150 at Citi
- 01/04/21 Barclays
- Goldman Sachs upgraded to Overweight with $362 target at Barclays
- 01/04/21 Barclays
- Goldman Sachs upgraded to Overweight from Equal Weight at Barclays
- 12/21/20 Morgan Stanley
- Goldman Sachs price target raised to $291 from $273 at Morgan Stanley
- 12/14/20 Keefe Bruyette
- Universal Banks upgraded to Overweight from Market Weight at Keefe Bruyette
- 01/04/21 Barclays
- Morgan Stanley upgraded to Overweight with $88 target at Barclays
- 01/04/21 Barclays
- Morgan Stanley upgraded to Overweight from Equal Weight at Barclays
- 12/11/20 Credit Suisse
- Morgan Stanley price target raised to $74 from $60 at Credit Suisse
- 01/04/21 Barclays
- Ally Financial upgraded to Overweight with $48 target at Barclays
- 01/04/21 Barclays
- Ally Financial upgraded to Overweight from Equal Weight at Barclays
- 12/21/20
- Fly Intel: Top five analyst initiations
- 12/21/20 RBC Capital
- Ally Financial initiated with an Outperform at RBC Capital
- 10/29/20
- Molson Coors says unable to provide updated detailed financial outlook
- 10/29/20
- Molson Coors reports Q3 EPS $1.62, consensus $1.02
- 10/28/20
- Notable companies reporting before tomorrow's open
- 10/22/20
- AT&T reports Q3 adjusted EPS 76c, consensus 76c
- 10/21/20
- Notable companies reporting before tomorrow's open
- 08/25/20
- Fly Intel: What to watch in Salesforce earnings report
- $1,164.82 /
+24.79 (+2.17%) - 11/05/20
- Mettler-Toledo sees FY21 adjusted EPS $27.50-$28.30, consensus $26.28
- 11/05/20
- Mettler-Toledo raises FY20 adj. EPS view to $24.87-$24.97 from $22.70-$23.20
- 11/05/20
- Mettler-Toledo sees Q4 adjusted EPS $8.60-$8.70, consensus $8.02
- 11/05/20
- Mettler-Toledo reports Q3 adjusted EPS $7.02, consensus $5.95
- 10/15/20
- Morgan Stanley reports Q3 EPS $1.66, consensus $1.28
- 10/14/20
- Notable companies reporting before tomorrow's open
- 11/03/20
- Humana sees Q4 adjusted EPS approximately ($2.40), consensus ($1.78)
- 11/03/20
- Humana narrows FY20 adj. EPS view to $18.50-$18.75 from $18.25-$18.75
- 11/03/20
- Humana reports Q3 adjusted EPS $3.08, consensus $2.81
- 11/02/20
- Notable companies reporting before tomorrow's open
- 10/14/20
- Goldman Sachs reports Q3 EPS $9.68, consensus $5.57
- 10/13/20
- Notable companies reporting before tomorrow's open
- 10/13/20
- Fly Intel: What to watch in next round of big banks' earnings reports
- 10/16/20
- Ally Financial reports Q3 adjusted EPS $1.25, consensus 68c
- 10/15/20
- Notable companies reporting before tomorrow's open
- 07/17/20
- Ally Financial reports Q2 EPS 61c, consensus 18c
- 12/28/20
- 'Wonder Woman 1984' collected $16.7M in opening weekend, Variety reports
- 12/21/20
- AT&T unhappy with offers for DirecTV, NY Post reports
- 12/10/20
- Disney, NBCUniversal unlikely to follow WarnerMedia's 2021 media plan, CNBC says
- 12/09/20
- AT&T receives offers above $15B in DirecTV auction, WSJ says
- 12/22/20
- 'James Bond' studio MGM Holdings exploring sale, WSJ reports
- 12/17/20
- JPMorgan lost out to Morgan Stanley on Eaton Vance, FT reports
- 11/10/20
- Supreme Court appears unlikely to topple ACA, USA Today says
- 12/31/20
- M&A activity rebounded into year-end to finish 2020 down just 5%, FT says
- 12/29/20
- Toshiba holds emergency board meeting amid investor demands, FT reports
- 12/28/20
- Goldman Sachs leads $65M financing in Echelon Fitness, Bloomberg says
- 12/22/20
- Tech companies win as SEC permits direct IPOs for cash raise, Bloomberg says
- 12/08/20
- Lowe's upgrade, Coca-Cola initiation among today's top calls on Wall Street
- 10/29/20
- Fly Intel: Pre-market Movers
- 07/30/20
- Fly Intel: Pre-market Movers
- 12/28/20
- AMC, Cinemark rise as WW84 scores highest box office opening of pandemic
- 12/28/20
- Fly Intel: Pre-market Movers
- 12/17/20
- Fly Intel: Wall Street's top stories for Thursday
- 12/17/20
- Fly Intel: Wall Street's top stories at midday
- 11/10/20
- Square, Wayfair upgrades among today's top calls on Wall Street
- 10/15/20
- Fly Intel: Wall Street's top stories for Thursday
- 10/15/20
- Fly Intel: Wall Street's top stories at midday
- 10/15/20
- Fly Intel: Pre-market Movers
- 12/01/20
- Fly Intel: What to watch in Salesforce's earnings report
- 11/14/20
- Week in review: How Trump's policies moved stocks
- 09/01/20
- Fly Intel: Wall Street's top stories for Tuesday
- 09/01/20
- Fly Intel: Wall Street's top stories at midday
- 11/30/20
- Apple upgrade, Slack downgrade among today's top calls on Wall Street
- 10/22/20
- Fly Intel: Wall Street's top stories for Thursday
- 10/22/20
- Fly Intel: Wall Street's top stories at midday
- 10/14/20
- Fly Intel: Wall Street's top stories for Wednesday
- 10/16/20
- Fly Intel: Pre-market Movers
- 07/15/20
- American Express downgrade among today's top calls on Wall Street
- 11/17/20
- Molson Coors put volume heavy and directionally bearish
- 09/29/20
- Early notable gainers among liquid option names on September 29th
- 12/30/20
- Notable open interest changes for December 30th
- 12/18/20
- Notable open interest changes for December 18th
- 12/17/20
- Notable open interest changes for December 17th
- 12/11/20
- Notable open interest changes for December 11th
- 12/31/20
- Morgan Stanley call volume above normal and directionally bullish
- 10/23/20
- Morgan Stanley call volume above normal and directionally bullish
- 10/15/20
- Unusually active option classes on open October 15th
- 12/23/20
- Unusually active option classes on open December 23rd
- 12/21/20
- Early notable gainers among liquid option names on December 21st
- 11/24/20
- Goldman Sachs call volume above normal and directionally bullish
- 11/12/20
- Goldman Sachs put volume heavy and directionally bearish
- 10/30/20
- Ally Financial put volume heavy and directionally bearish
- 10/20/20
- Ally Financial call volume above normal and directionally bullish
- 10/13/20
- Ally Financial call volume above normal and directionally bullish
- 09/24/20
- Ally Financial call volume above normal and directionally bullish
|
Upgrade
|
As previously reported,… As previously reported, RBC Capital analyst Frank Morgan upgraded Humana to Outperform from Sector Perform with a price target of $479, up from $429. The company is "well positioned" for strong growth in FY21 and beyond as its management anticipates an above-industry average growth in Individual Medicare Advantage, the analyst tells investors in a research note. Humana should also continue to benefit from improved operating leverage and efficiency initiatives, Morgan adds, boosting his FY21 EPS view to $21.78 from $21.42. ShowHide Related Items >><< - 12/18/20
- Deerfield Healthcare Technology Acquisitions agrees to merger with CareMax
- 12/16/20
- SI-Bone announces Humana coverage for iFuse in MIS SI joint fusion procedures
- 12/02/20
- Humana signs agreement with Prime West to bring medical care to Las Vegas
- 11/16/20
- Appaloosa exits Broadcom, Qualcomm positions, boosts PG&E stake
- 01/04/21 RBC Capital
- Humana upgraded to Outperform from Sector Perform at RBC Capital
- 12/22/20 JPMorgan
- Latest Georgia polling favors Republicans, says JPMorgan
- 12/17/20 Canaccord
- SI-Bone price target raised to $34 from $30 at Canaccord
- 11/30/20 SVB Leerink
- Humana price target lowered to $500 from $505 at SVB Leerink
- 11/03/20
- Humana sees Q4 adjusted EPS approximately ($2.40), consensus ($1.78)
- 11/03/20
- Humana narrows FY20 adj. EPS view to $18.50-$18.75 from $18.25-$18.75
- 11/03/20
- Humana reports Q3 adjusted EPS $3.08, consensus $2.81
- 11/02/20
- Notable companies reporting before tomorrow's open
- 11/10/20
- Supreme Court appears unlikely to topple ACA, USA Today says
- 12/01/20
- Fly Intel: What to watch in Salesforce's earnings report
- 11/14/20
- Week in review: How Trump's policies moved stocks
- 09/01/20
- Fly Intel: Wall Street's top stories for Tuesday
- 09/01/20
- Fly Intel: Wall Street's top stories at midday
|
Upgrade
|
RBC Capital analyst Frank… RBC Capital analyst Frank Morgan upgraded Humana to Outperform from Sector Perform with a $479 price target. ShowHide Related Items >><< - 12/18/20
- Deerfield Healthcare Technology Acquisitions agrees to merger with CareMax
- 12/16/20
- SI-Bone announces Humana coverage for iFuse in MIS SI joint fusion procedures
- 12/02/20
- Humana signs agreement with Prime West to bring medical care to Las Vegas
- 11/16/20
- Appaloosa exits Broadcom, Qualcomm positions, boosts PG&E stake
- 12/22/20 JPMorgan
- Latest Georgia polling favors Republicans, says JPMorgan
- 12/17/20 Canaccord
- SI-Bone price target raised to $34 from $30 at Canaccord
- 11/30/20 SVB Leerink
- Humana price target lowered to $500 from $505 at SVB Leerink
- 11/04/20 Oppenheimer
- Humana price target raised to $460 from $440 at Oppenheimer
- 11/03/20
- Humana sees Q4 adjusted EPS approximately ($2.40), consensus ($1.78)
- 11/03/20
- Humana narrows FY20 adj. EPS view to $18.50-$18.75 from $18.25-$18.75
- 11/03/20
- Humana reports Q3 adjusted EPS $3.08, consensus $2.81
- 11/02/20
- Notable companies reporting before tomorrow's open
- 11/10/20
- Supreme Court appears unlikely to topple ACA, USA Today says
- 12/01/20
- Fly Intel: What to watch in Salesforce's earnings report
- 11/14/20
- Week in review: How Trump's policies moved stocks
- 09/01/20
- Fly Intel: Wall Street's top stories for Tuesday
- 09/01/20
- Fly Intel: Wall Street's top stories at midday
|
Recommendations
|
The latest Real Clear… The latest Real Clear Politics polling averages increasingly favor the Republican Senate candidates in Georgia, JPMorgan analyst Gary Taylor tells investors in a research note. Betting markets currently give Republicans 76% odds, versus 68% last week, of winning at least one of the two seats, the analyst adds. Taylor sees the January 5 vote as a "miniature new clearing event" for Managed Care sector valuations, sentiment and performance. Humana (HUM) shares and the sector broadly would likely benefit most from a Republican win, while Centene (CNC) shares would likely benefit most from a Democratic sweep, says Taylor. ShowHide Related Items >><< - 12/08/20
- Massachusetts sues three UnitedHealth companies for 'misleading consumers'
- 12/04/20
- Eli Lilly, UnitedHealth partner on study of bamlanivimab for COVID-19
- 11/20/20
- UnitedHealth appoints Matthew Friedrich as CLO
- 11/19/20
- Molina Healthcare to begin CFO transition with retirement of Tom Tran in 2021
- 09/29/20
- Molina Healthcare to acquire Affinity Health Plan for $380M
- 07/17/20
- Evolent Health says Molina Healthcare to acquire assets of Passport Health
- 07/17/20
- Molina Healthcare to acquire certain assets of Passport Health Plan for ~$20M
- 12/18/20
- Deerfield Healthcare Technology Acquisitions agrees to merger with CareMax
- 12/16/20
- SI-Bone announces Humana coverage for iFuse in MIS SI joint fusion procedures
- 12/02/20
- Humana signs agreement with Prime West to bring medical care to Las Vegas
- 11/16/20
- Appaloosa exits Broadcom, Qualcomm positions, boosts PG&E stake
- 12/15/20
- Centene to acquire PANTHERx, terms not disclosed
- 12/07/20
- Centene names Brent Layton as Chief Business Development Officer
- 11/16/20
- Omega takes Alphabet Class A stake, exits position in JPMorgan
- 12/10/20
- Cigna appoints Brian Evanko as CFO
- 11/04/20
- Cigna rises 10.8%
- 11/04/20
- Cigna rises 9.5%
- 11/30/20
- Autohome falls -8.8%
- 10/27/20
- Autohome announces $168M investment in TTP Car
- 12/17/20 Canaccord
- SI-Bone price target raised to $34 from $30 at Canaccord
- 11/30/20 SVB Leerink
- Humana price target lowered to $500 from $505 at SVB Leerink
- 11/04/20 Oppenheimer
- Humana price target raised to $460 from $440 at Oppenheimer
- 11/04/20 Credit Suisse
- Humana price target raised to $465 from $423 at Credit Suisse
- 12/21/20 Deutsche Bank
- Centene price target lowered to $77 from $83 at Deutsche Bank
- 11/16/20 Citi
- Citi opens 'negative catalyst watch' on Centene
- 11/11/20 Piper Sandler
- Centene price target raised to $89 from $83 at Piper Sandler
- 11/02/20 Citi
- Citi opens 'positive catalyst watches' on Centene, HCA, Tenet into election
- 12/03/20 Deutsche Bank
- UnitedHealth price target raised to $359 from $332 at Deutsche Bank
- 12/02/20 BMO Capital
- UnitedHealth price target raised to $395 from $385 at BMO Capital
- 12/02/20 Truist
- UnitedHealth price target raised to $400 from $380 at Truist
- 12/02/20 Raymond James
- UnitedHealth price target raised to $405 from $355 at Raymond James
- 12/01/20 Macquarie
- Autohome price target raised to $95 from $90 at Macquarie
- 11/25/20
- Fly Intel: Top five analyst upgrades
- 11/25/20 Mizuho
- Autohome upgraded to Buy from Neutral at Mizuho
- 10/01/20 Deutsche Bank
- Autohome initiated with a Buy at Deutsche Bank
- 12/18/20 Mizuho
- Cigna price target raised to $229 from $220 at Mizuho
- 11/17/20 Oppenheimer
- Amazon's Pharmacy push should continue to disrupt supply chain, says Oppenheimer
- 11/17/20 Piper Sandler
- Amazon entry into Pharmacy makes 'great deal of sense,' says Piper Sandler
- 11/17/20 Goldman Sachs
- Goldman says Amazon news likely to pressure entire pharmacy supply chain
- 11/11/20 Piper Sandler
- Molina Healthcare price target raised to $266 from $213 at Piper Sandler
- 10/13/20 Truist
- Truist raises price targets on select Healthcare Services names
- 09/30/20 Truist
- Molina Healthcare risk-reward attractive after Affinity Health deal, says Truist
- 09/22/20 Stephens
- Molina Healthcare downgraded to Equal Weight from Overweight at Stephens
- 12/01/20
- UnitedHealth sees FY21 adjusted EPS $17.75-$18.25, consensus $18.33
- 12/01/20
- UnitedHealth raises FY20 adj. EPS view to approach $16.75 from $16.50-$16.75
- 10/14/20
- UnitedHealth raises FY20 adj. EPS view to $16.50-$16.75 from $16.25-$16.55
- 10/14/20
- UnitedHealth reports Q3 adj. EPS $3.51, consensus $3.09
- 10/28/20
- Molina Healthcare says FY21 improved with Affinity deal
- 10/28/20
- Molina Healthcare raises FY20 revenue view to roughly $19.6B from $18.8B
- 10/28/20
- Molina Healthcare reports Q3 adjusted EPS $3.36, consensus $2.16
- 10/28/20
- Notable companies reporting after market close
- 11/03/20
- Humana sees Q4 adjusted EPS approximately ($2.40), consensus ($1.78)
- 11/03/20
- Humana narrows FY20 adj. EPS view to $18.50-$18.75 from $18.25-$18.75
- 11/03/20
- Humana reports Q3 adjusted EPS $3.08, consensus $2.81
- 11/02/20
- Notable companies reporting before tomorrow's open
- 12/18/20
- Centene backs FY20 adjusted EPS view $4.90-$5.06, consensus $4.99
- 12/18/20
- Centene sees FY21 adjusted EPS $5.00-$5.30, consensus $5.44
- 10/27/20
- Centene raises FY20 adj. EPS view to $4.90-$5.06 from $4.76-$4.96
- 10/27/20
- Centene reports Q3 adj. EPS $1.26, consensus 96c
- 11/05/20
- Cigna sees FY20 adjusted EPS $18.30-$18.60, consensus $18.55
- 11/05/20
- Cigna reports Q3 adjusted EPS $4.41, consensus $4.24
- 11/04/20
- Notable companies reporting before tomorrow's open
- 11/30/20
- Autohome sees Q4 revenue $364.5M-$365.9M, consensus $379.99M
- 11/30/20
- Autohome reports Q3 EPS 1.04, consensus $1.01
- 08/25/20
- Autohome sees Q3 revenue $317.1M-$322.7M, consensus $324.53M
- 08/25/20
- Autohome reports Q2 adj. EPS $1.04, consensus $1.03
- 11/20/20
- Trump to release new rules aimed at lowering drug prices, WSJ reports
- 10/01/20
- Insurers reduce coverage for virtual doctors' visits, WSJ reports
- 09/29/20
- UnitedHealth buys DivvyDose, a rival of Amazon's PillPack, CNBC says
- 11/10/20
- Supreme Court appears unlikely to topple ACA, USA Today says
- 09/01/20
- Anthem-Cigna dispute over derailed merger ends in draw, WSJ reports
- 08/05/20
- Cigna sued by Justice Department for insurance fraud, Axios reports
- 12/01/20
- Fly Intel: Wall Street's top stories for Tuesday
- 12/01/20
- Fly Intel: Wall Street's top stories at midday
- 12/01/20
- Fly Intel: Pre-market Movers
- 11/17/20
- Fly Intel: Wall Street's top stories for Tuesday
- 07/30/20
- Fly Intel: After-Hours Movers
- 07/17/20
- Fly Intel: Pre-market Movers
- 12/01/20
- Fly Intel: What to watch in Salesforce's earnings report
- 11/14/20
- Week in review: How Trump's policies moved stocks
- 09/01/20
- Fly Intel: Wall Street's top stories for Tuesday
- 09/01/20
- Fly Intel: Wall Street's top stories at midday
- 10/27/20
- Fly Intel: Pre-market Movers
- 08/03/20
- Fly Insider: Montrose, Centene among week's notable insider transactions
- 07/28/20
- Fly Intel: Pre-market Movers
- 11/17/20
- Fly Intel: Wall Street's top stories at midday
- 11/17/20
- Pharmacy owners, suppliers slide after Amazon launches new offerings
- 11/30/20
- Fly Intel: Pre-market Movers
- 08/25/20
- Fly Intel: Pre-market Movers
- 10/14/20
- Unusually active option classes on open October 14th
- 07/15/20
- Unusually active option classes on open July 15th
- 10/13/20
- Centene put volume heavy and directionally bearish
- 09/21/20
- Centene put volume heavy and directionally bearish
- 09/01/20
- Centene put volume heavy and directionally bearish
- 08/31/20
- Centene call volume above normal and directionally bullish
- 11/04/20
- Early notable gainers among liquid option names on November 4th
- 10/30/20
- Cigna put volume heavy and directionally bearish
- 10/01/20
- Cigna put volume heavy and directionally bearish
- 09/15/20
- Cigna put volume heavy and directionally bearish
|